These 2 ASX biotechs reported strong clinical data from Phase 2 trials
Clinical data is the best way for investors in ASX biotechs to tell whether or not it has a chance…
Will war in Israel impact stocks? Is it 1973 all over again?
Will war in Israel impact stocks? So far it hasn’t impacted the ASX significantly, although it has hit the Israel…
Dimerix (ASX:DXB) signs a A$230m deal!
Dimerix (ASX:DXB) achieved one of the most important milestones a biotech must achieve before commercialising a drug or medical device.…
Noxopharm (ASX:NOX) is up over 100% after getting Orphan Drug Designation – but is it that big a deal?
Noxopharm (ASX:NOX) is the ASX’s biggest winner, climbing as much as 166% higher than it closed yesterday. And it is all…
Here’s why this pot stock gained a stunning 40% this morning
As of 10.30am this morning, the biggest gaining ASX stock with news was pot stock ECS Botanics (ASX:ECS), all thanks…
Mixed messages for ASX lithium stocks in 2023
ASX lithium stocks … there may be further downside! Our own Stuart Roberts explains the changing dynamics of the…
Meet First Lithium (ASX:FL1) – the newest lithium stock on the ASX gained more than 50% today
Look at the ASX’s winners board this morning and you’ll notice First Lithium (ASX:FL1) rose more than 50% today. It…
Botanix Pharmaceuticals (ASX:BOT) shareholders have to wait another 12 months for FDA approval
Botanix Pharmaceuticals (ASX:BOT) was hoping to get FDA approval this week, but its hopes were dashed because the FDA wants…
These 2 ASX biotech stocks are hoping to get FDA approval this week
It is set to be a big week for 2 ASX biotech stocks, which are awaiting news from the FDA.…
Bear market? It seems the bears aren’t finished with us yet …
Bear market? It seems the bears aren’t finished with us yet… Stuart Roberts presents his perspective on the current bear-dominated…
The 3 successful listings of ARM, Klaviyo and Instacart bode well for the ASX IPO market
After a rough couple of years, the listings of ARM, Klaviyo and Instacart, their individual successes and the fact there…
Why uranium stocks Basin Energy (ASX:BSN) and Alligator Energy (ASX:AGE) crashed 20% today
Although uranium has been the best performing commodity in 2023, this has not stopped Basin Energy (ASX:BSN) and Alligator Energy…
Codrus Minerals (ASX:CDR) was this morning’s largest mover on the ASX – here’s why
Codrus Minerals (ASX:CDR) is a rare earths explorer on the ASX that was this morning’s biggest gainer, surging from 7c…
Why lithium stocks Wildcat Resources, Bubalus Resources and Venus Metals surged on Monday
It was a good morning to be a shareholder of lithium stocks Wildcat Resources (ASX:WC8), Bubalus Resources (ASX:BUS) and Venus…
ASX chip stocks could do well on the back of ARM’s solid 25% trading debut gain
ARM is the biggest IPO of the year so far If you like ASX chip stocks, the one thing that…